FDA Hosts Public Workshop on Design of Clinical Trials for Tuberculosis Treatment

Summary

The Food and Drug Administration (FDA) is hosting a public workshop to discuss scientific issues in clinical trial design for the treatment of tuberculosis, bringing together public health experts, healthcare providers, academia, and industry to share perspectives on antimicrobial drug development for tuberculosis.